Events
Stay up-to-date with the latest events, including faculty presentations, career events for students and alumni, and so much more.
Loading view.
Phi Delta Chi Blood Drive
Pharm Sci Seminar – Herman Sintim
Chronic myeloid leukemia, CML, is driven by ABL1 and the introduction of highly effective kinase inhibitors, such as imatinib, has resulted in a 5-year survival rate for CML to approach 90%.
PD&E: DPH-1 Identity & Self-Reflection
DPH 1 Students Notified of Alternate Site Approval
DPH-1 students will receive an email from Tina Rundle with notification for alternate site approval